Skip to main content
OpenTrials
Completed

NCT Number: NCT05725681

Satiety of High-Protein Ramen Noodles

The aim of this study is to determine if high-protein instant ramen noodles acutely increase satiety, reduce hunger, and improve blood sugar levels compared to standard instant ramen noodles in generally healthy young to middle aged adults. In addition, investigators aim to test if intake of high-protein instant ramen noodles reduces caloric intake at the next meal compared to standard instant ramen noodles.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nutrition and Metabolic Health Initiative

Lubbock, Texas, 79409, United States

About this study

The aim of this study is to determine if high-protein instant ramen noodles acutely increase satiety, reduce hunger, and improve blood sugar levels compared to standard instant ramen noodles in generally healthy young to middle aged adults. In addition, investigators aim to test if intake of high-protein instant ramen noodles reduces caloric intake at the next meal compared to standard instant ramen noodles. Subjects meeting the eligibility criteria will be recruited and offered a 2-condition, randomized, crossover postprandial study. Participants will be asked to limit physical activity to a specified level, consume a standardized meal at night and report to the clinic after a 12 h overnight fast. At our clinic, in random order, participants will consume: 1) one portion of high-protein instant ramen noodles (71 g; Chef Woo, Borealis Foods); 2) an isocaloric, weight matched portion of standard instant ramen noodles. The participants will have to finish consuming the noodles within 15 minutes. Water will be provided at the time of breakfast and for the next two hours. In the 4-hours following the ramen breakfast, blood will be sampled at regular intervals (0 minutes - before starting the breakfast, and 30, 60, 120 and 180 minutes after stopping breakfast) for hunger and satiety hormones (i.e., glucagon like peptide-1, peptide-YY, and ghrelin), and glucose and insulin. Visual Analogue Scales will also be administered to assess subjective hunger and satiety. At 4-hours, a buffet-style lunch will be provided and caloric intake at the meal will be covertly assessed. Subjects will leave the clinic at this point. The process will be repeated for the second condition after at least 7 d washout period.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Body Mass Index 20-30 kg/m2

Exclusion criteria

  • Unwilling or unable to have an IV catheter inserted
  • Body weight <110 pounds
  • Diabetes (any type)
  • Fasting capillary glucose ≥100 mg/dL
  • Unstable systemic medical condition

•>10% change in body weight in the prior 3 months

  • Medications that affect appetite or glucose regulation
  • Prior bariatric surgery
  • Uncontrolled hypertension (i.e., unmedicated blood pressure >130/90 mmHg)
  • Intolerance, dislike or allergy to the study food
  • Current or recent (within 6 months) tobacco use
  • High alcohol consumption (>14 drinks/week)
  • Currently following a weight loss diet
  • Irregular menstrual cycle
  • Currently pregnant or lactating
  • Principal investigator discretion (e.g., disrespectful or inappropriate interactions with study staff

Treatment and study plan

High protein ramen

Other

Participants will be served one portion of high-protein instant ramen noodles [CHEF WOO Roasted Chicken Flavor Ramen Cup Noodles, Borealis Foods; 71 g]

Standard ramen

Other

Participants will be served one portion of standard instant ramen noodles [RAMEN EXPRESS Chicken Flavor Ramen Cup Noodle Chef Woo, Borealis Foods; 71 g]

Primary outcomes

  1. Appetite Score Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Calculated as satiety + fullness + (100 - hunger) + (100 - prospective food consumption)/4. Questions 1-4 from the Visual Analogue Scale will be used to assess satiety, fullness, hunger and prospective food consumption and calculate the Appetite Score

Secondary outcomes

  1. Ghrelin Area Under the Curve (pg/mL*180 minutes)

    Time frame: 0 to 180 minutes

    Measured in plasma

  2. Glucagon like peptide-1 (GLP-1) Area Under the Curve (pg/mL*180 minutes)

    Time frame: 0 to 180 minutes

    Measured in plasma

  3. Peptide-YY (PYY) Area Under the Curve (pg/mL*180 minutes)

    Time frame: 0 to 180 minutes

    Measured in plasma

  4. Glucose Area Under the Curve (mg/dL*180 minutes)

    Time frame: 0 to 180 minutes

    Measured in plasma

  5. Insulin Area Under the Curve (mUI*180 minutes)

    Time frame: 0 to 180 minutes

    Measured in serum

  6. Perceived Hunger Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  7. Perceived Satiety Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  8. Perceived Fullness Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  9. Prospective Food Consumption Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  10. Minimum ghrelin (pg/mL)

    Time frame: 0 to 180 minutes

    Measured in plasma

  11. Peak Glucagon like peptide-1 (GLP-1) (pg/mL)

    Time frame: 0 to 180 minutes

    Measured in plasma

  12. Peak Peptide-YY (PYY) (pg/mL)

    Time frame: 0 to 180 minutes

    Measured in plasma

  13. Peak Glucose (mg/dL)

    Time frame: 0 to 180 minutes

    Measured in plasma

  14. Peak Insulin (mUI)

    Time frame: 0 to 180 minutes

    Measured in serum

  15. Desire to eat something fatty Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  16. Desire to eat something salty Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  17. Desire to eat something savory Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  18. Desire to eat something sweet Area Under the Curve (mm*180 minutes)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  19. Energy intake at the buffet lunch (kcal)

    Time frame: Served approximately 3.5 hours following the ramen meal test

    Food consumed during the buffet lunch

  20. Perceived hunger at peak GLP1 (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  21. Perceived satiety at peak GLP1 (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  22. Perceived fullness at peak GLP1 (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  23. Perceived hunger at peak PYY (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  24. Perceived satiety at peak PYY (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  25. Perceived fullness at peak PYY (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  26. Perceived hunger at minimum ghrelin (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  27. Perceived satiety at minimum ghrelin (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

  28. Perceived fullness at minimum ghrelin (mm)

    Time frame: 0 to 180 minutes

    Assessed by visual analogue scale.

Sponsors and collaborators

Lead sponsor

Texas Tech University

Other

Registry information

Official study title

The Role of High-Protein Instant Ramen Noodles in Inducing and Maintaining Satiety: Acute, Randomized, Crossover Study

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Feb 13, 2023
Registry last updated
Apr 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.